20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Stroke in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 13 (76.47) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Booz, GW; Fan, F; Fan, L; Li, M; Roman, RJ; Shekhar, S; Varghese, K | 1 |
| Booz, GW; Cunningham, MW; Fan, F; Pabbidi, MR; Shekhar, S; Wang, S | 1 |
| Cheng, G; Li, J; Li, Y; Li, Z; Liu, Y; Lu, L; Teng, G; Zhan, M | 1 |
| Attwell, D; Buchan, AM; Gesslein, B; Hall, CN; Hamilton, NB; Lauritzen, M; Mishra, A; O'Farrell, FM; Reynell, C; Sutherland, BA | 1 |
| Ergul, A; Hoda, MN; Li, W; Luo, P; Maddipati, KR; Seki, T; Wang, MH; Zhang, Y; Zheng, X | 1 |
| Chen, H; Li, J; Liao, D; Wang, C; Wu, L; Yi, X | 1 |
| Al-Shabrawey, M; Huang, H; Wang, MH | 1 |
| Liao, D; Lin, J; Yi, X; Zhang, B; Zhou, Q | 1 |
| Liao, D; Wang, C; Wu, L; Yi, X; Zhang, B | 1 |
| Booz, GW; Elliott, MR; Fan, F; Ge, Y; Hirata, T; Lv, W; Muroya, Y; Roman, RJ | 1 |
| Han, Z; Lin, J; Liu, P; Yi, X; Zhou, Q | 1 |
| Lin, J; Wang, C; Yi, X; Zhou, Q | 1 |
| Almgren, P; Berglund, G; Engström, G; Fava, C; Hedblad, B; Lippi, G; Melander, O; Minuz, P; Montagnana, M; Rosberg, L | 1 |
| Dunn, KM; Falck, J; Flasch, AK; Harder, DR; Renic, M; Roman, RJ | 1 |
| Barden, A; Beer, CD; Blacker, D; Croft, KD; Hankey, GJ; Mori, TA; Puddey, IB; Ward, NC | 1 |
| Bandou, K; Cambj-Sapunar, L; Doi, M; Harder, DR; Kametani, S; Miyata, N; Okuyama, S; Omura, T; Roman, RJ; Sato, M; Seki, T; Tanaka, Y; Taniguchi, K | 1 |
| Bies, RR; Graham, SH; Kochanek, PM; Poloyac, SM; Zhang, Y | 1 |
4 review(s) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Stroke
| Article | Year |
|---|---|
Conflicting Roles of 20-HETE in Hypertension and Stroke.
Topics: Animals; Disease Progression; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Models, Biological; Polymorphism, Genetic; Stroke | 2019 |
Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Ischemia; Endothelial Cells; Genetic Therapy; Humans; Hydroxyeicosatetraenoic Acids; Hyperbaric Oxygenation; Immunomodulation; Inflammation; Macrophages; Microglia; MicroRNAs; Neuroprotective Agents; Oligonucleotides; Oxidative Stress; Signal Transduction; Stroke | 2018 |
Cyclooxygenase- and cytochrome P450-derived eicosanoids in stroke.
Topics: Arachidonic Acid; Cytochrome P-450 Enzyme System; Eicosanoids; Humans; Hydroxyeicosatetraenoic Acids; Models, Biological; Prostaglandin-Endoperoxide Synthases; Receptors, Prostaglandin E; Stroke; Subarachnoid Hemorrhage | 2016 |
Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology.
Topics: Animals; Blood Vessels; Brain Injuries, Traumatic; Endothelium, Vascular; Humans; Hydroxyeicosatetraenoic Acids; Muscle, Smooth, Vascular; Neovascularization, Physiologic; Platelet Aggregation; Reperfusion Injury; Signal Transduction; Stroke; Subarachnoid Hemorrhage; Vasculitis | 2016 |
13 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Stroke
| Article | Year |
|---|---|
Astrocytic cytochrome P450 4A/20-hydroxyeicosatetraenoic acid contributes to angiogenesis in the experimental ischemic stroke.
Topics: Angiogenesis Inducing Agents; Animals; Astrocytes; Brain Ischemia; Cell Proliferation; Cytochrome P-450 CYP4A; Disease Models, Animal; Endothelial Cells; Hydroxyeicosatetraenoic Acids; Male; Mice; Mice, Inbred C57BL; Microcirculation; Neovascularization, Pathologic; Stroke; Vascular Endothelial Growth Factor A | 2019 |
Capillary pericytes regulate cerebral blood flow in health and disease.
Topics: Animals; Arterioles; Blood-Brain Barrier; Brain Ischemia; Capillaries; Cell Death; Cerebellum; Cerebral Cortex; Cerebrovascular Circulation; Dinoprostone; Excitatory Amino Acid Antagonists; Female; Functional Neuroimaging; Glutamic Acid; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Pericytes; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Glutamate; Signal Transduction; Stroke; Vasoconstriction; Vasodilation | 2014 |
Combined therapy with COX-2 inhibitor and 20-HETE inhibitor reduces colon tumor growth and the adverse effects of ischemic stroke associated with COX-2 inhibition.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Ischemia; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytochrome P-450 CYP4A; Dinoprostone; Humans; Hydroxyeicosatetraenoic Acids; Lactones; Male; Mice; Mice, Inbred C57BL; Rats; Stroke; Sulfones; Time Factors; Tumor Burden | 2014 |
CYP Genetic Variants, CYP Metabolite Levels, and Symptomatic Carotid Stenosis in Ischemic Stroke Patients.
Topics: Aged; Arachidonic Acids; Brain Ischemia; Carotid Arteries; Carotid Stenosis; Cytochrome P-450 Enzyme System; Epoxide Hydrolases; Female; Genetic Variation; Genotype; Humans; Hydroxyeicosatetraenoic Acids; Male; Middle Aged; Polymorphism, Single Nucleotide; Risk; Stroke; Ultrasonography | 2016 |
Interaction Between CYP4F2 rs2108622 and CPY4A11 rs9333025 Variants Is Significantly Correlated with Susceptibility to Ischemic Stroke and 20-Hydroxyeicosatetraenoic Acid Level.
Topics: Aged; Brain Ischemia; Case-Control Studies; Cytochrome P-450 CYP4A; Cytochrome P450 Family 4; Epistasis, Genetic; Female; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Humans; Hydroxyeicosatetraenoic Acids; Male; Middle Aged; Polymorphism, Single Nucleotide; Stroke | 2016 |
Interactions Among CYP2C8, EPHX2, and CYP4A11 Variants and CYP Plasma Metabolite Levels in Ischemic Stroke.
Topics: Aged; Biomarkers; Brain Ischemia; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP4A; Epoxide Hydrolases; Female; Follow-Up Studies; Genetic Variation; Genotype; Humans; Hydroxyeicosatetraenoic Acids; Male; Prognosis; Stroke | 2016 |
20-Hydroxyeicosatetraenoic Acid as a Predictor of Neurological Deterioration in Acute Minor Ischemic Stroke.
Topics: Brain Ischemia; Disease Progression; Humans; Hydroxyeicosatetraenoic Acids; Prognosis; Prospective Studies; Stroke | 2016 |
CYP Genetic Variants, CYP Metabolite Levels, and Neurologic Deterioration in Acute Ischemic Stroke in Chinese Population.
Topics: Aged; Aged, 80 and over; Asian People; Biomarkers; Brain Ischemia; Chi-Square Distribution; China; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Eicosanoids; Epoxide Hydrolases; Female; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Hydroxyeicosatetraenoic Acids; Male; Middle Aged; Nerve Degeneration; Odds Ratio; Phenotype; Polymorphism, Single Nucleotide; Prospective Studies; Risk Factors; Stroke; Time Factors | 2017 |
The V433M variant of the CYP4F2 is associated with ischemic stroke in male Swedes beyond its effect on blood pressure.
Topics: Analysis of Variance; Anthropometry; Brain Ischemia; Cohort Studies; Cytochrome P-450 CYP4A; Female; Gene Expression Regulation; Genetic Predisposition to Disease; Genotype; Heterozygote; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Kaplan-Meier Estimate; Male; Middle Aged; Polymorphism, Genetic; Probability; Proportional Hazards Models; Sex Factors; Stroke | 2008 |
Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats.
Topics: Amidines; Animals; Blood Pressure; Cerebral Arteries; Cerebrovascular Circulation; Cytochrome P-450 CYP4A; Disease Models, Animal; Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; Hypertension; Infarction, Middle Cerebral Artery; Isoenzymes; Male; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Severity of Illness Index; Stroke; Time Factors; Up-Regulation | 2008 |
Cytochrome P450 metabolites of arachidonic acid are elevated in stroke patients compared with healthy controls.
Topics: 8,11,14-Eicosatrienoic Acid; Arachidonic Acid; Case-Control Studies; Cytochrome P-450 Enzyme System; F2-Isoprostanes; Female; Humans; Hydroxyeicosatetraenoic Acids; Male; Middle Aged; Oxidative Stress; Stroke | 2011 |
Beneficial effects of a new 20-hydroxyeicosatetraenoic acid synthesis inhibitor, TS-011 [N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide], on hemorrhagic and ischemic stroke.
Topics: Animals; Brain; Carotid Arteries; Cerebral Hemorrhage; Cerebral Infarction; Cerebrovascular Circulation; Collagenases; Cytochrome P-450 CYP4A; Formamides; Hydroxyeicosatetraenoic Acids; Infarction, Middle Cerebral Artery; Infusions, Intra-Arterial; Isoenzymes; Male; Morpholines; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Stroke | 2005 |
Protective effect of the 20-HETE inhibitor HET0016 on brain damage after temporary focal ischemia.
Topics: Amidines; Animals; Brain Injuries; Brain Ischemia; Cerebrovascular Circulation; Cytochrome P-450 Enzyme System; Hydroxyeicosatetraenoic Acids; Male; Microsomes; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Stroke; Vasoconstriction | 2006 |